Reviva Pharmaceuticals Holdings (RVPH) Payables (2018 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) recorded Payables of $2.6 million in Q2 2026, down 48.8% from $5.08 million a year earlier but up 12.2% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, Reviva Pharmaceuticals Holdings reported Payables of $3.42 million, down 49.3% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
- Across earlier years, Payables came in at $6.74 million in FY2024 (+75.1%), $3.85 million in FY2023 (+9.3%) and $3.52 million in FY2022.
- Quarterly Payables has ranged from $420,783 in Q3 2021 to $8.86 million in Q3 2024 over the past five years.
- On a year-over-year basis, Payables has declined for four consecutive quarters, with an average decline of 8.5% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 612.7% in Q2 2022, against a decline of 53.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.32 million (Q1 2026), $3.42 million (Q4 2025) and $5.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Reviva Pharmaceuticals Holdings | 6.16 Mn | 6.16 Mn | - | 2.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.60 Mn |
| Mar 31, 2026 | 2.32 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 5.08 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 6.74 Mn |
| Sep 30, 2024 | 8.86 Mn |
| Jun 30, 2024 | 4.90 Mn |
| Mar 31, 2024 | 6.05 Mn |
| Dec 31, 2023 | 3.85 Mn |
| Sep 30, 2023 | 5.50 Mn |
| Jun 30, 2023 | 2.87 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | 3.52 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 509,583.00 |
| Sep 30, 2021 | 420,783.00 |
API Access
Reviva Pharmaceuticals Holdings Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();